Stephen Stone, MD

Instructor in Pediatrics, Endocrinology and Diabetes
Researcher, Pediatric Research

View Content

Stephen Stone is interested in applying the concepts of personalized/precision medicine to the diagnosis and treatment of atypical forms of diabetes with an emphasis on insulin resistance disorders. In this manner, Stone combines traditional endocrine and metabolic phenotyping with cutting-edge genomic techniques. He is currently using this strategy in order in order to define a novel insulin resistance syndrome related to fibroblast growth factor 21 (FGF-21).